BioCentury
ARTICLE | Financial News

Theraclone completes venture financing

April 1, 2013 7:00 AM UTC

Theraclone Sciences Inc., Seattle, Wash. Business: Infectious, Inflammation Date completed: 3/25/13 Type: Venture financing Raised: $3 million Investors: MidCap Financial; Silicon Valley Bank Note: Th...